Performance of current guidelines for coronary heart disease prevention: Optimal use of the Framingham-based risk assessment

Atherosclerosis

Volumn 216, Issue 2, 2011, Pages 452-457

  Murphy, Timothy P ^a,b   Dhangana, Rajoo ^a,b,c   Pencina, Michael J ^d,e   Zafar, Abdul M ^a,b   D'Agostino, Ralph B ^d,e  

^a RHODE ISLAND HOSPITAL   (United States)

^b BROWN UNIVERSITY   (United States)

^c VANDERBILT UNIVERSITY   (United States)

^d BOSTON UNIVERSITY   (United States)

^e Boston University   (United States)

Author keywords

Cardiac biomarkers; Cardiovascular diseases; Cardiovascular diseases risk factors; Coronary heart disease; Framingham Risk Score

Indexed keywords

ADULT; ARTICLE; DEATH; DIAGNOSTIC ACCURACY; FEMALE; FOLLOW UP; FRAMINGHAM RISK SCORE; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY;

AGED; ALGORITHMS; AREA UNDER CURVE; BIOLOGICAL MARKERS; CARDIOLOGY; COHORT STUDIES; CORONARY DISEASE; FEMALE; GUIDELINES AS TOPIC; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; RISK; RISK ASSESSMENT; RISK FACTORS; ROC CURVE; TREATMENT OUTCOME;

EID: 79957999651     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2011.02.020     Document Type: Article

References (18)

1. Kannel W.B., McGee D., Gordon T. A general cardiovascular risk profile: the Framingham study. Am J Cardiol 1976, 38:46-51.
2. Anonymous Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation 2002, 106:3143-3421.
3. Anonymous Prevention of coronary heart disease in clinical practice. Recommendations of the second joint task force of European and other societies on coronary prevention. Eur Heart J 1998, 19:1434-1503.
4. Grundy S.M., Pasternak R., Greenland P., Smith S., Fuster V. AHA/ACC scientific statement: assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology. J Am Coll Cardiol 1999, 34:1348-1359.
5. Law M.R., Wald N.J. Risk factor thresholds: their existence under scrutiny. BMJ 2002, 324(7353):1570-1576.
6. Pletcher M.J., Lazar L., Bibbins-Domingo K., et al. Comparing impact and cost-effectiveness of primary prevention strategies for lipid-lowering. Ann Intern Med 2009, 150(4):243-254.
7. Anonymous The Atherosclerosis Risk in Communities (ARIC) study: design and objectives. The ARIC investigators. Am J Epidemiol 1989, 129:687-702.
8. Fried L.P., Borhani N.O., Enright P., et al. The Cardiovascular Health study: design and rationale. Ann Epidemiol 1991, 1:263-276.
9. Psaty B.M., Kuller L.H., Bild D., et al. Methods of assessing prevalent cardiovascular disease in the Cardiovascular Health study. Ann Epidemiol 1995, 5:270-277.
10. Ives D.G., Fitzpatrick A.L., Bild D.E., et al. Surveillance and ascertainment of cardiovascular events. The Cardiovascular Health study. Ann Epidemiol 1995, 5:278-285.
11. Fowkes F.G., Murray G.D., et al. Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. JAMA 2008, 300:197-208. Ankle Brachial Index Collaboration.
12. Greenland P., Smith S.C., Grundy S.M. Improving coronary heart disease risk assessment in asymptomatic people: role of traditional risk factors and noninvasive cardiovascular tests. Circulation 2001, 104:1863-1867.
13. Shapiro D.E. The interpretation of diagnostic tests. Stat Methods Med Res 1999, 8:113-134.
14. Sutton A.J., Cooper N.J., Goodacre S., Stevenson M. Integration of meta-analysis and economic decision modeling for evaluating diagnostic tests. Med Decis Making 2008, 28:650-667.
15. Taylor T.N. The medical economics of stroke. Drugs 1997, 54(3):51-57.
16. Russell M.W., Huse D.M., Drowns S., Hamel E.C., Hartz S.C. Direct medical costs of coronary artery disease in the United States. Am J Cardiol 1998, 81:1110-1115.
17. Foraker R.E., Rose K.M., Whitsel E.A., Suchindran C.M., Wood J.L., Rosamond W.D. Neighborhood socioeconomic status, Medicaid coverage and medical management of myocardial infarction: atherosclerosis risk in communities (ARIC) community surveillance. BMC Public Health 2010, 10:632.
18. Pencina M.J., D'Agostino R.B., D'Agostino R.B., Vasan R.S. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 2008, 27:157-172.